Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country
PURPOSELow rates of germline genetic testing (GGT) for breast cancer (BC) have been reported globally, with limited data from low- and middle-income countries (LMICs). In this study, we used real-world data to assess the GGT rate for BC in an LMIC and identified barriers to its use.METHODSWe analyze...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Society of Clinical Oncology
2025-04-01
|
| Cyfres: | JCO Global Oncology |
| Mynediad Ar-lein: | https://ascopubs.org/doi/10.1200/GO-24-00337 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
